# Continuous Infusion Versus Intermittent Bolus Hydrocortisone in Septic Shock

> **NCT07695337** · PHASE4 · COMPLETED · sponsor: **Benha University** · enrollment: 110 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Hydrocortisone Continuous Infusion
- **DRUG:** Hydrocortisone Intermittent Bolus

## Key facts

- **NCT ID:** NCT07695337
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-01-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695337, "Continuous Infusion Versus Intermittent Bolus Hydrocortisone in Septic Shock". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07695337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*